Search Results for: RB1

199 interactions involving RB1 - RB transcriptional corepressor 1 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
RNF123 ring finger protein 123
  • Ub-specific processing proteases
  • Antigen processing: Ubiquitination & Proteasome degradation
SERPINB2 serpin family B member 2
  • Dissolution of Fibrin Clot
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Urokinase
  • Tenecteplase
  • Lanoteplase
SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
  • RMTs methylate histone arginines
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
SMYD2 SET and MYND domain containing 2
  • PKMTs methylate histone lysines
  • Regulation of TP53 Activity through Methylation
SUV39H1 suppressor of variegation 3-9 homolog 1
  • PKMTs methylate histone lysines
  • SIRT1 negatively regulates rRNA expression
ZBTB16 zinc finger and BTB domain containing 16
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Skeletal defects, genital hypoplasia, and mental retardation
  • Acute myeloid leukemia (AML)
AATF apoptosis antagonizing transcription factor
  • NRAGE signals death through JNK
BAG1 BAG cochaperone 1
  • Regulation of HSF1-mediated heat shock response
  • (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
CBX1 chromobox 1
  • HCMV Early Events
CEBPE CCAAT enhancer binding protein epsilon
  • Transcriptional regulation of granulopoiesis
  • Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
CHN2 chimerin 2
  • Rho GTPase cycle
CREG1 cellular repressor of E1A stimulated genes 1
  • Neutrophil degranulation
DGKZ diacylglycerol kinase zeta
  • Effects of PIP2 hydrolysis
  • alpha-Tocopherol succinate
DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A
  • G0 and Early G1
  • N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
  • Fostamatinib
FBP1 fructose-bisphosphatase 1
  • Gluconeogenesis
  • Adenosine phosphate
  • 2,5-Anhydroglucitol-1,6-Biphosphate
  • {4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol
  • Mdl-29951
  • Fructose-6-phosphate
  • MB-07803
  • Managlinat dialanetil
  • N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE
  • 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
  • 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE
  • 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE
  • Fructose-1,6-bisphosphatase deficiency
FBP2 fructose-bisphosphatase 2
  • Gluconeogenesis
HMGA2 high mobility group AT-hook 2
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
ID2 inhibitor of DNA binding 2
  • NGF-stimulated transcription
KDM5A lysine demethylase 5A
  • HDMs demethylate histones
KMT5C lysine methyltransferase 5C
  • PKMTs methylate histone lysines

Page 8 out of 10 pages